Anxiolytic Effect of Virtual Reality Immersion Versus Midazolam Premedication in Patients Undergoing Dacryocystorhinostomy Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorCairo University

About this trial

The aim is to investigate the anxiolytic effect, and hemodynamic stability of using virtual reality immersion in adult patients undergoing Dacryocystorhinostomy (DCR) operation under general anesthesia and to compare its effect to that of using Midazolam as a premedication.

Eligibility criteria

Qualifiers

Aged 18-65.

Both sexes.

American Society of Anesthesiologists (ASA) classification: I - II.

Patient undergoing Dacryocystorhinostomy Surgery (DCR) operation under general anesthesia.

Disqualifiers

Patient refusal.

Patients with cardiac diseases.

Patients with renal diseases.

Patients with drug sensitivity and seizures.

Trial design

Treatments tested in this trial

  • Virtual Reality Group
  • Midazolam Group

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators